Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 03, 2020

BUY
$29.01 - $74.23 $116,040 - $296,920
4,000 New
4,000 $292,000
Q1 2020

Jun 19, 2020

SELL
$27.51 - $57.29 $110,040 - $229,160
-4,000 Closed
0 $0
Q4 2019

Jan 31, 2020

BUY
$40.86 - $57.65 $163,440 - $230,600
4,000 New
4,000 $218,000

Others Institutions Holding BHVN

About Biohaven Pharmaceutical Holding Co Ltd.


  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.65B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Supplemental Annuity Collective Trust Of Nj Portfolio

Follow Supplemental Annuity Collective Trust Of Nj and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Supplemental Annuity Collective Trust Of Nj, based on Form 13F filings with the SEC.

News

Stay updated on Supplemental Annuity Collective Trust Of Nj with notifications on news.